Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy

There are no licensed therapeutics or vaccines available against Zika virus (ZIKV) to counteract its potential for congenital disease. Antibody-based countermeasures targeting the ZIKV envelope protein have been hampered by concerns for cross-reactive responses that induce antibody-dependent enhance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wessel, Alex W., Kose, Nurgun, Bombardi, Robin G., Roy, Vicky, Chantima, Warangkana, Mongkolsapaya, Juthathip, Edeling, Melissa A., Nelson, Christopher A., Bosch, Irene, Alter, Galit, Screaton, Gavin R., Fremont, David H., Crowe, James E., Diamond, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572419/
https://www.ncbi.nlm.nih.gov/pubmed/33077712
http://dx.doi.org/10.1038/s41467-020-19096-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572419/
https://www.ncbi.nlm.nih.gov/pubmed/33077712
http://dx.doi.org/10.1038/s41467-020-19096-y

Ejemplares similares